Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 50
Filter
1.
Clin Neurol Neurosurg ; 190: 105649, 2020 03.
Article in English | MEDLINE | ID: mdl-31881415

ABSTRACT

OBJECTIVE: Management of peripheral nerve sheath tumors (PNST) in Neurofibromatosis Type 2 (NF2) is complicated by frequent involvement of major peripheral nerves and concern that these tumors may be plexiform and/or involve multiple fascicles. Hybrid histologic features of both schwannoma and neurofibroma have been described in NF2-associated tumors, although the incidence of this phenotype in PNSTs is unknown. We sought to define the outcomes of surgery for tumors involving major peripheral nerves in NF2 and identify the rate of hybrid histology in PNSTs. PATIENTS AND METHODS: Functional outcomes of surgery for patients with tumors on major (named) peripheral nerves were recorded. Histopathologic analyses were performed on all available excised tumors. RESULTS: Nineteen operations were performed in 12 patients with NF2, for resection of 28 PNSTs. Among 11 tumors involving major peripheral nerves, 10 involved nerves related to motor function. Presenting symptoms in this group included pain (9) and weakness (4). Median tumor diameter was 3.4 cm (range:2.2-10.3 cm). Gross-total resection was achieved in 10 cases. Motor function was stable/improved in 10 cases but diminished after one case involving a small motor fascicle. All tumors involved a single fascicle. Histopathologic analyses of 21 available specimens revealed 19 pure schwannomas. In two cases (10 %) hybrid features of both schwannoma and neurofibroma were identified, with mast cells within regions consistent with neurofibroma. CONCLUSIONS: PNSTs can be resected safely in NF2, even if they involve major peripheral nerves. A small proportion (10 %) of these tumors harbor hybrid histologic features, which may explain reports of plexiform or multi-fascicular tumors in NF2.


Subject(s)
Brachial Plexus/surgery , Neurilemmoma/surgery , Neurofibroma/surgery , Neurofibromatosis 2/surgery , Peripheral Nervous System Neoplasms/surgery , Tibial Nerve/surgery , Adult , Female , Humans , Male , Middle Aged , Muscle Weakness/physiopathology , Nerve Sheath Neoplasms/pathology , Nerve Sheath Neoplasms/physiopathology , Nerve Sheath Neoplasms/surgery , Neurilemmoma/pathology , Neurilemmoma/physiopathology , Neurofibroma/pathology , Neurofibroma/physiopathology , Neurofibromatosis 2/pathology , Neurosurgical Procedures/methods , Pain/physiopathology , Peripheral Nervous System Neoplasms/pathology , Peripheral Nervous System Neoplasms/physiopathology , Treatment Outcome , Tumor Burden , Young Adult
2.
Article in English | MEDLINE | ID: mdl-31435075

ABSTRACT

Oral squamous cell carcinoma (OSCC) is a growing problem worldwide. Several biological and molecular criteria have been established for making a prognosis of OSCC. One of the most important factors affecting the risk of tumor recurrence and overall prognosis is perineural invasion and bone invasion. Perineural invasion is defined as a tumor spreading and the ability of tumor cells to penetrate around or through the nerve tissue. Perineural invasion can cause the tumor to spread to distant areas from the primary tumor location. One possible explanation for this is the formation of microenvironment in the perineural space which may contain cellular factors that act on both nerve tissue and some types of tumor tissues. Bone invasion by OSCC has major implications for tumor staging, choice of treatment, outcome and quality of life. Oral SCCs invade the mandibular or maxillary bone through an erosive, infiltrative or mixed pattern that correlates with clinical behavior. Bone resorption by osteoclasts is an important step in the process of bone invasion by oral SCCs. Some cytokines (e.g. TNFα and PTHrP) lead to receptor activator of NF-κB ligand (RANKL) expression or osteoprotegerin (OPG) suppression in oral SCC cells and in cancer stromal cells to induce osteoclastogenesis. Oral SCCs provide a suitable microenvironment for osteoclastogenesis to regulate the balance of RANKL and OPG. A more molecular-based clinical staging and tailor-made therapy would benefit patients with bone invasion by OSCC.


Subject(s)
Biomarkers, Tumor/blood , Bone Neoplasms/physiopathology , Carcinoma, Squamous Cell/physiopathology , Cytokines/blood , Mouth Neoplasms/physiopathology , Neoplasm Invasiveness/physiopathology , Neoplasm Recurrence, Local/physiopathology , Nerve Sheath Neoplasms/physiopathology , Adult , Aged , Aged, 80 and over , Bone Neoplasms/etiology , Carcinoma, Squamous Cell/complications , Female , Humans , Male , Middle Aged , Mouth Neoplasms/complications , Neoplasm Recurrence, Local/etiology , Nerve Sheath Neoplasms/etiology , Predictive Value of Tests , Prognosis
3.
Auris Nasus Larynx ; 45(4): 871-874, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29089157

ABSTRACT

Schwanomatosis is the third most common form of neurofibromatosis. Schwanomatosis affecting the vagus nerve is particularly rare. In this report, we describe an extremely rare case bilateral vagus nerve schwanomatosis in a 45-year-old male patient. The patient initially presented with bilateral neck tumors and hoarseness arising after thoracic surgery. We performed left neck surgery in order to diagnose and resect the remaining tumors followed by laryngeal framework surgery to improve vocal cord closure and symptoms of hoarseness. Voice recovery was successfully achieved after surgery. An appropriate diagnosis and surgical tumor resection followed by phonosurgery improved patient quality of life in this rare case.


Subject(s)
Neoplasms, Multiple Primary/diagnostic imaging , Nerve Sheath Neoplasms/diagnostic imaging , Neurilemmoma/diagnostic imaging , Vagus Nerve Diseases/diagnostic imaging , Hoarseness/etiology , Hoarseness/physiopathology , Humans , Laryngoplasty , Male , Middle Aged , Neoplasms, Multiple Primary/complications , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/physiopathology , Nerve Sheath Neoplasms/complications , Nerve Sheath Neoplasms/pathology , Nerve Sheath Neoplasms/physiopathology , Neurilemmoma/complications , Neurilemmoma/pathology , Neurilemmoma/physiopathology , Recovery of Function , Vagus Nerve Diseases/complications , Vagus Nerve Diseases/pathology , Vagus Nerve Diseases/physiopathology , Vocal Cords
4.
Acta Orthop Traumatol Turc ; 52(3): 236-239, 2018 May.
Article in English | MEDLINE | ID: mdl-29110923

ABSTRACT

Malignant triton tumor (MTT) is a rare variant of malignant peripheral nerve sheath tumor (MPNST) made up of both malignant schwannoma cells and malignant rhabdomyoblasts. A 26-years-old male patient was admitted with an asymptomatic gluteal mass. Magnetic resonance imaging showed heterogeneous soft tissue mass and he underwent open biopsy. Malignant peripheral nerve sheath tumor was diagnosed. He was given adjuvant chemotherapy following the removal of the tumor with hip disarticulation. The tumor was diagnosed as "malignant triton tumor" based on pathological examination including immunohistochemical studies. There were no signs of metastasis but recurrence was observed at 9 months follow up. MTT is usually associated with Neurofibromatosis 1 and located in head, neck region. In this case sporadic involvement of gluteal region and aggressive behavior of the lesion despite radical surgery was demonstrated.


Subject(s)
Chemotherapy, Adjuvant , Hip , Nerve Sheath Neoplasms , Neurilemmoma , Orthopedic Procedures , Adult , Biopsy/methods , Buttocks , Chemotherapy, Adjuvant/adverse effects , Chemotherapy, Adjuvant/methods , Hip/pathology , Hip/surgery , Humans , Magnetic Resonance Imaging/methods , Male , Neoplasm Recurrence, Local , Nerve Sheath Neoplasms/pathology , Nerve Sheath Neoplasms/physiopathology , Nerve Sheath Neoplasms/surgery , Neurilemmoma/pathology , Neurilemmoma/physiopathology , Neurilemmoma/surgery , Orthopedic Procedures/adverse effects , Orthopedic Procedures/methods , Schwann Cells/pathology
5.
PLoS One ; 12(8): e0183155, 2017.
Article in English | MEDLINE | ID: mdl-28813519

ABSTRACT

Malignant peripheral nerve sheath tumors (MPNST) are rare, highly aggressive sarcomas that can occur spontaneously or from pre-existing plexiform neurofibromas in neurofibromatosis type1 (NF1) patients. MPNSTs have high local recurrence rates, metastasize easily, are generally resistant to therapeutic intervention and frequently fatal for the patient. Novel targeted therapeutic strategies are urgently needed. Standard treatment for patients presenting with advanced disease is doxorubicin based chemotherapy which inhibits the actions of the enzyme topoisomerase IIα (TOP2A). Recent molecular studies using murine models and cell lines identified the bromodomain containing protein 4 (BRD4) and enhancer of zeste homolog 2 (EZH2) as novel targets for MPNST treatment. We investigated the expression and potential use of BRD4, EZH2 and TOP2A as therapeutic targets in human NF1-derived MPNSTs. The transcript levels of BRD4, EZH2 and TOP2A were determined in paired formalin-fixed paraffin-embedded (FFPE) neurofibroma/MPNST samples derived from the same NF1 patient and in a set of plexiform neurofibromas, atypical neurofibromas and MPNST. We further examined the effect on cell viability of genetic or pharmacological inhibition of BRD4, EZH2 and TOP2A in an MPNST cell line panel. Our results indicated that in MPNST samples BRD4 mRNA levels were not upregulated and that MPNST cell lines were relatively insensitive to the bromodomain inhibitor JQ1. We corroborated that EZH2 mRNA expression is increased in MPNST but failed to confirm its reported pivotal role in MPNST pathogenesis as EZH2 knockdown by siRNA did not interfere with cellular proliferation and viability. Finally, the relation between TOP2A levels and sensitivity for doxorubicin was examined, confirming reports that TOP2A mRNA levels were overexpressed in MPNST and showing that MPNST cell lines exhibited relatively high TOP2A protein levels and sensitivity to doxorubicin. We tentatively conclude that the potential for effective therapeutic intervention in MPNST by targeting BRD4, EZH2 and TOP2A individually, may be limited. Clinical studies are necessary to ultimately prove the relevance of BRD4 and EZH2 inhibition as novel therapeutic strategies for MPNST.


Subject(s)
Antigens, Neoplasm/genetics , DNA Topoisomerases, Type II/genetics , DNA-Binding Proteins/genetics , Enhancer of Zeste Homolog 2 Protein/genetics , Gene Expression Regulation, Neoplastic , Nerve Sheath Neoplasms/physiopathology , Neurofibroma/physiopathology , Nuclear Proteins/metabolism , Transcription Factors/metabolism , Adolescent , Adult , Aged , Antibiotics, Antineoplastic/pharmacology , Cell Cycle Proteins , Cell Line , Cell Survival/drug effects , Child , Child, Preschool , DNA-Binding Proteins/antagonists & inhibitors , Doxorubicin/pharmacology , Enhancer of Zeste Homolog 2 Protein/antagonists & inhibitors , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , In Vitro Techniques , Male , Middle Aged , Nerve Sheath Neoplasms/genetics , Neurofibroma/genetics , Nuclear Proteins/antagonists & inhibitors , Poly-ADP-Ribose Binding Proteins , Transcription Factors/antagonists & inhibitors , Young Adult
8.
Neurology ; 88(17): 1615-1622, 2017 Apr 25.
Article in English | MEDLINE | ID: mdl-28341644

ABSTRACT

OBJECTIVE: To determine ultrasonographic peripheral nerve involvement in patients with asymptomatic neurofibromatosis type 1 (NF1). METHODS: Thirteen asymptomatic and 4 minimally symptomatic patients with NF1 were included in this cross-sectional pilot study to detect asymptomatic abnormalities of the brachial plexus and upper and lower extremity nerves. Patients underwent clinical examination, nerve conduction studies (NCS), and high-resolution ultrasonography (HRUS). RESULTS: HRUS showed abnormalities in 16 patients (94.1%). Neurofibromas were identified in 10 patients (58.8%): localized neurofibromas were found in 3 patients (17.6%), plexiform neurofibromas in 3 (17.6%), and both in 4 (23.5%). In 6 patients (35.3%), only nerve enlargement without an abnormal fascicular pattern was observed. Severe involvement of the peripheral nervous system with multiple plexiform neurofibromas was observed in 7 patients (41.2%), while 4 patients (23.5%) had no or only minor involvement. Both NCS and HRUS were performed on 73 individual nerve segments. In 5.5%, abnormalities were found with both tests; in 50.7%, only with HRUS; and in 1.4%, only with NCS. CONCLUSIONS: HRUS frequently showed subclinical involvement of the peripheral nerves in NF1, also when NCS were normal. HRUS findings ranged from normal to widespread peripheral nerve involvement. Because the presence of plexiform neurofibromas and the benign tumor load are risk factors for the development of a malignant peripheral nerve sheath tumor, HRUS may be a useful tool to identify a subgroup of patients who could benefit from regular follow-up.


Subject(s)
Nerve Sheath Neoplasms/diagnostic imaging , Neurofibromatosis 1/diagnostic imaging , Ultrasonography , Adult , Aged , Brachial Plexus/diagnostic imaging , Brachial Plexus/physiopathology , Cross-Sectional Studies , Female , Humans , Lower Extremity/diagnostic imaging , Lower Extremity/innervation , Lower Extremity/physiopathology , Male , Middle Aged , Nerve Sheath Neoplasms/etiology , Nerve Sheath Neoplasms/physiopathology , Neural Conduction , Neurofibromatosis 1/complications , Neurofibromatosis 1/physiopathology , Pilot Projects , Upper Extremity/diagnostic imaging , Upper Extremity/innervation , Upper Extremity/physiopathology , Young Adult
9.
J Reconstr Microsurg ; 32(5): 371-7, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26872028

ABSTRACT

Background Schwannomas are the most common primary solitary tumor among peripheral nerve sheath tumors. The occurrence of transient or permanent neurological deficits after schwannoma resection is more common than previously recognized. Here, the neurological deficits before and after surgical resection of schwannomas in the upper extremities were examined. Methods The study included 43 upper-extremity schwannomas that were treated surgically between January 2000 and July 2013. The neurological status of each patient (such as pain, sensory disturbances, and motor disturbances) was evaluated preoperatively, immediately postoperatively, and at the final postoperative follow-up. Results Out of the 43 cases, 34 cases exhibited neurological symptoms before the operation, and in 31 of the 34 cases, neurological symptoms were either reduced or disappeared after the surgery. In 20 of the 43 cases, new neurological deficits that had not been observed preoperatively were noted immediately postoperatively; the newly acquired neurological deficits disappeared over time in 5 of the 20 cases. Significantly, more newly acquired neurological deficits remained in cases where the tumor was located in the upper arm and elbow than in cases where the tumor was located in the distal forearm. Conclusion New neurological deficits occurred after surgery in about half of the cases. This ratio was higher than expected, suggesting that schwannoma resection is not always a complication-free operation. Therefore, patients should be informed preoperatively about the possibility of neurological deficits. Furthermore, extreme care should be taken not to damage the affected and uninvolved nerves during surgery.


Subject(s)
Microsurgery , Nerve Sheath Neoplasms/physiopathology , Nerve Sheath Neoplasms/surgery , Neurilemmoma/physiopathology , Neurilemmoma/surgery , Neurosurgical Procedures , Upper Extremity/pathology , Upper Extremity/surgery , Adolescent , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Period , Retrospective Studies , Treatment Outcome , Young Adult
10.
Apoptosis ; 21(5): 594-608, 2016 May.
Article in English | MEDLINE | ID: mdl-26892009

ABSTRACT

Sec6 and Sec8, which are components of the exocyst complex, has been concerned with various roles independent of its role in secretion, such as cell migration, invadopodia formation, cytokinesis, glucose uptake, and neural development. Given the vital roles of the exocyst complex in cellular and developmental processes, the disruption of its function may be closely related to various diseases such as cancer, diabetes, and neuronal disorders. Malignant peripheral nerve sheath tumors (MPNSTs) have high malignant potential and poor prognosis because of aggressive progression and metastasis. To date, no chemotherapeutic agents have been validated for MPNSTs treatment because how MPNSTs are resistant to chemotherapeutic agents remains unknown. This study demonstrates that combination of doxorubicin and sorafenib induces apoptosis in MPNST cells through downregulation of B cell lymphoma protein 2 (Bcl-2), Bcl-2-related protein long form of Bcl-x (Bcl-xl), and myeloid cell leukemia 1 (Mcl-1). Moreover, both Sec6 and Sec8 levels decreased after treatment with doxorubicin and sorafenib and were found to be associated with Bcl-2 and Mcl-1 expressions, but not Bcl-xl. Although Sec8 was found to be involved in the regulation of both Bcl-2 and Mcl-1 at the mRNA level, Sec6 regulated Bcl-2 at the mRNA level and the binding affinity of F-box and WD repeat domain containing 7 and Mcl-1, thereby controlling Mcl-1 at the protein level. Bcl-2 or Mcl-1 mRNA suppression by Sec6 or Sec8 depletion resulted in significant changes in nuclear factor-kappa B, cAMP response element, and p53 transcriptional activity. These results suggest that Sec6 and Sec8 are therapeutic target molecules in MPNST.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Myeloid Cell Leukemia Sequence 1 Protein/genetics , Nerve Sheath Neoplasms/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , Vesicular Transport Proteins/metabolism , Apoptosis , Cell Line, Tumor , Doxorubicin/pharmacology , Gene Expression Regulation, Neoplastic , Humans , Membrane Potential, Mitochondrial , Myeloid Cell Leukemia Sequence 1 Protein/metabolism , Nerve Sheath Neoplasms/metabolism , Nerve Sheath Neoplasms/physiopathology , Niacinamide/analogs & derivatives , Niacinamide/pharmacology , Phenylurea Compounds/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Sorafenib , Transcription, Genetic , Vesicular Transport Proteins/antagonists & inhibitors , bcl-X Protein/genetics , bcl-X Protein/metabolism
11.
J Clin Neuromuscul Dis ; 15(2): 52-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24263031

ABSTRACT

Intraneural perineuriomas are rare tumors of the peripheral nerves with unique immunohistochemical findings. In this report, we highlight the clinical and imaging findings of an adolescent male with histologically proven intraneural perineurioma involving multiple nerves. The salient features included a clinically progressive course, imaging evidence of involvement of long segments of multiple nerves, enlargement of individual fascicles within the affected nerves, and intense contrast enhancement of the enlarged fascicles. The identification of enlarged fascicles with intense contrast enhancement within the affected and distended nerve segments may aid in distinguishing intraneural perineurioma from other tumors affecting the peripheral nerves.


Subject(s)
Brachial Plexus Neuritis/physiopathology , Median Nerve/physiopathology , Nerve Sheath Neoplasms/physiopathology , Neural Conduction/physiology , Peripheral Nervous System Neoplasms/physiopathology , Radial Nerve/physiopathology , Adolescent , Brachial Plexus Neuritis/etiology , Brachial Plexus Neuritis/pathology , Humans , Male , Median Nerve/pathology , Nerve Sheath Neoplasms/complications , Nerve Sheath Neoplasms/pathology , Peripheral Nervous System Neoplasms/complications , Peripheral Nervous System Neoplasms/pathology , Radial Nerve/pathology
12.
J Am Vet Med Assoc ; 241(9): 1194-201, 2012 Nov 01.
Article in English | MEDLINE | ID: mdl-23078567

ABSTRACT

OBJECTIVE: To determine the electrophysiological changes in dogs with peripheral nerve sheath tumors (PNSTs), evaluate the prevalence of these changes, assess the correlation between spontaneous activity in epaxial muscles and proximal invasion by the tumor, and evaluate whether knowledge of electrophysiological changes could be helpful in the imaging diagnosis via CT or MRI. DESIGN: Retrospective case series. ANIMALS: 51 dogs with a histologic (n = 18) or a suspected (33) diagnosis of PNST. PROCEDURES: Clinical, postmortem, and histologic reports and details of electrodiagnostic procedures and CT or MRI reports were studied. Twenty-four CT and 6 MRI reports for dogs with PNSTs were reviewed by a single observer blinded to the diagnosis. RESULTS: Only 2 of the 51 dogs had no electrophysiological changes. The most commonly affected muscles were those innervated by the radial, ulnar, median, tibial-sciatic, and peroneal nerves. Abnormal spontaneous epaxial muscle activity was significantly more frequent in the group with foraminal or spinal invasion by the tumors. Knowledge of the electrophysiological changes increased diagnostic accuracy of CT. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that electrophysiological studies may be sensitive for the detection of PNST and helpful in the imaging diagnosis. Epaxial electromyographic abnormalities appeared to be predictive for intervertebral or vertebral canal invasion by PNSTs in dogs.


Subject(s)
Dog Diseases/physiopathology , Muscle Neoplasms/veterinary , Muscle, Skeletal/physiopathology , Nerve Sheath Neoplasms/veterinary , Action Potentials/physiology , Animals , Dogs , Electromyography/veterinary , Female , Magnetic Resonance Imaging , Male , Muscle Neoplasms/physiopathology , Muscle, Skeletal/innervation , Neoplasm Invasiveness , Nerve Sheath Neoplasms/physiopathology , Neural Conduction/physiology , Retrospective Studies , Tomography, X-Ray Computed
13.
J Clin Neuromuscul Dis ; 14(1): 28-33, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22922579

ABSTRACT

We present the case of a 67-year-old man with a malignant peripheral nerve sheath tumor (MPNST) affecting the brachial plexus. He presented with progressive right upper extremity paresthesias, numbness, weakness, and severe pain. Nerve conduction studies/electromyography demonstrated a right lower and middle trunk predominant brachial plexopathy. Three-tesla magnetic resonance imaging of the brachial plexus showed a soft tissue mass with central necrosis and cystic changes and irregular contrast enhancement. Positron emission tomography showed increased fluorodeoxyglucose uptake within the mass. Targeted fascicular nerve biopsy revealed hypercellular tumor, featuring atypical cells with mitotic figures and limited immunoreactivity for S-100 protein. The findings were those of an MPNST. The effects on the variably involved fascicles were also seen in teased fiber preparations, paraffin sections, and through immunohistochemistry. This case illustrates the presentation of this rare type of tumor, and characteristic neuroimaging and pathologic features of MPNSTs.


Subject(s)
Brachial Plexus/physiopathology , Nerve Fibers/pathology , Nerve Sheath Neoplasms/physiopathology , Peripheral Nervous System Neoplasms/physiopathology , Aged , Biopsy , Humans , Magnetic Resonance Imaging , Male , Nerve Sheath Neoplasms/diagnosis , Neural Conduction/physiology , Peripheral Nervous System Neoplasms/diagnosis , Upper Extremity/physiopathology
15.
Muscle Nerve ; 44(4): 593-6, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21922473

ABSTRACT

A young man presented with progressive motor weakness and atrophy of the ulnar muscles of his left hand over a period of more than 2 years. Electrodiagnostic studies indicated an ulnar nerve lesion, but it was not localized. High-resolution sonography of the ulnar nerve revealed an enlarged and hypoechogenic ulnar nerve at an unusual location, namely 12.5 cm proximal to the medial epicondyle. Histology showed that this was an intraneural perineurioma. High-resolution sonography of the ulnar nerve is very useful in the discovery of this unusual location of nerve pathology and may assist in its early detection.


Subject(s)
Arm , Nerve Sheath Neoplasms/pathology , Ulnar Neuropathies/pathology , Action Potentials/physiology , Arm/innervation , Arm/physiopathology , Electric Stimulation , Humans , Male , Mucin-1/metabolism , Nerve Sheath Neoplasms/physiopathology , Neural Conduction/physiology , Reaction Time/physiology , S100 Proteins/metabolism , Ulnar Neuropathies/physiopathology , Young Adult
16.
Neurosurgery ; 69(1): E245-50; discussion E250, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21796069

ABSTRACT

BACKGROUND AND IMPORTANCE: The main therapeutic approach for malignant peripheral nerve sheath tumors (MPNSTs) of the brachial plexus is wide local excision. Sacrifice of some--occasionally all--elements of the brachial plexus often is required to obtain complete resection, and therefore can be associated with significant morbidity. While peripheral nerve repair is commonly used in the setting of traumatic nerve injury, little is known about its potential use in the treatment of MPNST. CLINICAL PRESENTATION: We present a patient with an enlarging right neck mass who was diagnosed with MPNST of the brachial plexus. The patient underwent gross total resection of the tumor, requiring sectioning of the upper trunk of the brachial plexus, as well as associated divisions. Following resection, sural nerve grafts were used to connect the C5 nerve root to the anterior division of the upper trunk and the spinal accessory nerve to the suprascapular nerve, whereas a triceps branch of the radial nerve was coapted directly to the anterior division of the axillary nerve. CONCLUSION: By 20 months after surgery, the patient had regained significant strength in her upper trunk distribution and demonstrated no evidence of tumor recurrence. Brachial plexus reconstruction offers a potentially valuable surgical adjunct to MPNST treatment.


Subject(s)
Brachial Plexus/surgery , Nerve Sheath Neoplasms/pathology , Nerve Sheath Neoplasms/surgery , Peripheral Nervous System Neoplasms/pathology , Peripheral Nervous System Neoplasms/surgery , Plastic Surgery Procedures/methods , Adult , Brachial Plexus/pathology , Female , Humans , Magnetic Resonance Imaging , Nerve Sheath Neoplasms/physiopathology , Peripheral Nervous System Neoplasms/physiopathology
17.
Neurol Med Chir (Tokyo) ; 50(11): 1044-9, 2010.
Article in English | MEDLINE | ID: mdl-21123996

ABSTRACT

Spinal nerve sheath tumors (NSTs) originating from the C1 or C2 level are unique from both anatomical and clinical perspectives. Surgical technique to accomplish radical but safe resection of these tumors is described in 8 cases treated during the past 5 years. Surgical measures included positioning the patient in the lateral oblique position, unilateral posterior approach, exposure of the tumor along the surgical plane of the dural or perineural boundary, and proximal and distal amputation of the tumor with resection of dural penetration. Excessive bone resection and soft tissue manipulation were unnecessary. Microscopic complete removal of the tumor was accomplished in seven of eight cases. Subtotal resection was done in one case where the tumor extended beyond the vertebral artery. Functional assessment demonstrated satisfactory improvement after surgery in all cases. Surgery-related complications were not encountered in any case. Exposure of the tumor along the surgical plane of the dural or perineural boundary may be the key procedure required to accomplish radical but safe resection of spinal NSTs originating from the C1 or C2 level.


Subject(s)
Cervical Vertebrae/surgery , Nerve Sheath Neoplasms/surgery , Neurosurgical Procedures/methods , Peripheral Nervous System Neoplasms/surgery , Spinal Nerves/surgery , Adult , Aged , Female , Humans , Male , Middle Aged , Nerve Sheath Neoplasms/pathology , Nerve Sheath Neoplasms/physiopathology , Peripheral Nervous System Neoplasms/pathology , Peripheral Nervous System Neoplasms/physiopathology , Spinal Nerves/pathology , Spinal Nerves/physiopathology , Young Adult
18.
J Pediatr Hematol Oncol ; 32(7): 548-53, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20686424

ABSTRACT

PURPOSE: The role of angiogenesis in the transformation of peripheral neurofibroma (PNF) to malignant peripheral nerve sheath tumor (MPNST) in neurofibromatosis type 1 (NF1) remains elusive and forms the objective of this study. EXPERIMENTAL DESIGN: Archival tissue from 5 children with NF1 and PNF, who developed MPNST between the ages of 8 and 15 years were analyzed for differences in microvasculature. The role of proangiogenic growth factors such as Vascular Endothelial Growth Factor (VEGF), and its receptors Flk-1 and Flt-1, and vessel maturity, defined as von Willebrand factor (vWf), α-smooth muscle actin+ (SMA+), were evaluated by immuno-histochemistry. RESULTS: A qualitative evaluation of the vasculature showed predominantly α-SMA+/vWf+ more stable vessels in PNF, and an irregular meshwork of α-SMA-/vWf+ endothelial cells structures in MPNST. In NF and PNF tumor cells were VEGF-, in contrast to VEGF+ tumor cells in MPNST. If present, the VEGF stain was confined mainly to the perivascular spaces in PNF, unlike the mainly stromal VEGF stain in MPNST. VEGF receptors also manifested a tumor stage-specific pattern. Flk-1 and Flt-1 were restricted to the mature, well-formed vasculature in PNF, but exhibited a diffuse pattern in MPNST. CONCLUSION: Our study provides a rare opportunity to document consistent and histologically detectable differences in the vascular organization of PNF and MPNST. It permits a pair-wise evaluation of the malignant conversion of benign PNF into its malignant counterpart, in the same patients. The phenotypic variations and characteristics of the vessels in these tumors are consistent with the idea that a strong proangiogenic drive contributes to the progressive growth in MPNST.


Subject(s)
Cell Transformation, Neoplastic , Neovascularization, Pathologic/physiopathology , Nerve Sheath Neoplasms/physiopathology , Neurofibroma, Plexiform/physiopathology , Neurofibromatosis 1/physiopathology , Actins/metabolism , Adolescent , Child , Female , Humans , Male , Microcirculation/physiology , Neovascularization, Pathologic/pathology , Nerve Sheath Neoplasms/blood supply , Nerve Sheath Neoplasms/pathology , Neurofibroma, Plexiform/blood supply , Neurofibroma, Plexiform/pathology , Neurofibromatosis 1/pathology , Tissue Banks , Vascular Endothelial Growth Factor A/metabolism , Vascular Endothelial Growth Factor Receptor-1/metabolism , Vascular Endothelial Growth Factor Receptor-2/metabolism , von Willebrand Factor/metabolism
19.
Mol Cell Biochem ; 344(1-2): 267-76, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20680410

ABSTRACT

Plexiform neurofibromas commonly found in patients with Neurofibromatosis type I (NF1) have a 5% risk of being transformed into malignant peripheral nerve sheath tumors (MPNST). Germline mutations in the NF1 gene coding for neurofibromin, which is a Ras GTPase activating protein (RasGAP) and a negative regulator of Ras, result in an upregulation of the Ras pathway. We established a direct connection between neurofibromin deficiency and downstream effectors of Ras in cell lines from MPNST patients by demonstrating that knockdown of NF1 expression using siRNA in a NF1 wild type MPNST cell line, STS-26T, activates the Ras/ERK1,2 pathway and increases AP-1 binding and activity. We believe this is the first time the transactivation of AP-1 has been linked directly to neurofibromin deficiency in a disease relevant MPNST cell line. Previously, we have shown that N-Ras is constitutively activated in cell lines derived from independent MPNSTs from NF1 patients. We therefore sought to analyze the role of the N-Ras pathway in deregulating AP-1 transcriptional activity. We show that STS-26T clones conditionally expressing oncogenic N-Ras show increased phosphorylated ERK1,2 and phosphorylated JNK expression concomitant with increased AP-1 activity. MAP kinase pathways (ERK1,2 and JNK) were further examined in ST88-14, a neurofibromin-deficient MPNST cell line. The basal activity of ERK1,2 but not JNK was found to increase AP-1 activity. These experiments further confirmed the link between the loss of neurofibromin and increased activity of Ras/MAP kinase pathways and the activation of downstream transcriptional mechanisms in MPNSTs from NF1 patients.


Subject(s)
Genes, ras , Nerve Sheath Neoplasms/physiopathology , Neurofibromin 1/physiology , Base Sequence , Cell Line, Tumor , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Nerve Sheath Neoplasms/genetics , Oligodeoxyribonucleotides , Phosphorylation
20.
J Clin Neurosci ; 17(10): 1317-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20594851

ABSTRACT

We describe the first patient with an extradural, extramedullary Ewing's sarcoma tumor mimicking a nerve sheath tumor with no overt evidence of metastasis. A 28-year-old woman with no past medical history presented with a progressive 3-year history of low back pain and right-sided lower extremity radiculopathy after having failed conservative therapies. MRI of the lumbar spine revealed a right-sided enhancing, dumbbell-shaped lesion at the right neural foramen appearing to originate from the L4 nerve root, suspicious for a peripheral nerve sheath tumor or schwannoma. The patient and findings are discussed in the context of the literature, including an update on the relatively recent diagnostic redesignation of the Ewing's sarcoma family tumors.


Subject(s)
Bone Neoplasms/diagnosis , Nerve Sheath Neoplasms/physiopathology , Sarcoma, Ewing/diagnosis , Adult , Bone Neoplasms/surgery , Female , Humans , Magnetic Resonance Imaging , Sarcoma, Ewing/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...